China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA:600062)

Market Cap	18.91B -5.3%
Revenue (ttm)	10.95B -4.1%
Net Income	1.58B -6.2%
EPS	1.53 -6.8%
Shares Out	1.03B
PE Ratio	11.96
Forward PE	10.74
Dividend	0.47 (2.57%)
Ex-Dividend Date	Oct 28, 2025

Volume	6,910,557
Average Volume	7,916,457
Open	18.52
Previous Close	18.51
Day's Range	18.25 - 18.55
52-Week Range	17.34 - 22.14
Beta	0.07
RSI	39.04
Earnings Date	Mar 20, 2026

About SHA:600062

China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in the People’s Republic of China. The company offers pharmaceutical products for blood pressure, blood sugar, injection, lipid-lowering, pediatrics, nephrology, API, pharmaceutical, psychiatry/neurology, anticoagulation, oncology, women's health, anesthesia, and analgesia. The company was founded in 1939 and is headquartered in Beijing, the People’s Republic of China. China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a subsidiary of Beijing...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1939
• Employees: 13,414
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600062

Financial Performance

In 2024, SHA:600062's revenue was 11.21 billion, a decrease of -0.87% compared to the previous year's 11.31 billion. Earnings were 1.63 billion, a decrease of -2.55%.